{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:37:22Z","timestamp":1764103042427,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clml.2019.09.602","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T18:55:39Z","timestamp":1569956139000},"page":"e259-e269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Zhen","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Qiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Pei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-Cheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-Bai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.09.602_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/1074-7613(95)90167-1","article-title":"Targeted disruption of the FLK2\/FLT3 gene leads to deficiencies in primitive hematopoietic progenitors","volume":"3","author":"Mackarehtschian","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.clml.2019.09.602_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clml.2019.09.602_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ni.1615","article-title":"The receptor tyrosine kinase FLT3 is required for dendritic cell development in peripheral lymphoid tissues","volume":"9","author":"Waskow","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clml.2019.09.602_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood.V99.1.310","article-title":"FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model","volume":"99","author":"Kelly","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib5","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1038\/sj.onc.1208933","article-title":"FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model","volume":"24","author":"Lee","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.clml.2019.09.602_bib6","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1182\/blood-2004-11-4430","article-title":"FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model","volume":"105","author":"Grundler","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib7","doi-asserted-by":"crossref","first-page":"21113","DOI":"10.1073\/pnas.1310559110","article-title":"FLT3\/D835Y mutation knock-in mice display less aggressive disease compared with FLT3\/internal tandem duplication (ITD) mice","volume":"110","author":"Bailey","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clml.2019.09.602_bib8","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.cellsig.2009.06.002","article-title":"Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and","volume":"21","author":"Masson","year":"2009","journal-title":"FLT3. Cell Signal"},{"key":"10.1016\/j.clml.2019.09.602_bib9","first-page":"432","article-title":"Prevalence and prognostic significance of FLT3 gene mutations in patients with acute leukaemia: analysis of patients from the Shanghai Leukaemia Co-operative Group","volume":"38","author":"Wang","year":"2010","journal-title":"J\u00a0Intl Med Res"},{"key":"10.1016\/j.clml.2019.09.602_bib10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood.V116.21.1031.1031","article-title":"High rate of FLT3 mutations in adult ETP-ALL","volume":"116","author":"Neumann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib11","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib12","doi-asserted-by":"crossref","first-page":"e53190","DOI":"10.1371\/journal.pone.0053190","article-title":"FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors","volume":"8","author":"Neumann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2019.09.602_bib13","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/bcj.2011.49","article-title":"Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations","volume":"2","author":"Neumann","year":"2012","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2019.09.602_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2004-01-0168","article-title":"Activating FLT3 mutations in CD117\/KIT+ T-cell acute lymphoblastic leukemias","volume":"104","author":"Paietta","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/AJCPR3N3JMSYLPFG","article-title":"CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T\/myeloid acute leukemia","volume":"137","author":"Hoehn","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.09.602_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood.V97.1.89","article-title":"Prevalence and prognostic significance of FLT3 internal tandem duplication in pediatric acute myeloid leukemia","volume":"97","author":"Meshinchi","year":"2001","journal-title":"Blood"},{"year":"2017","series-title":"Functional Assessment of Novel Diagnostic FLT3 Mutations and Inhibition by Kinase Inhibitors. Poster Presented at: European Hematology Association (EHA22); June 22-25","author":"Tarlock","key":"10.1016\/j.clml.2019.09.602_bib18"},{"key":"10.1016\/j.clml.2019.09.602_bib19","doi-asserted-by":"crossref","first-page":"e89560","DOI":"10.1371\/journal.pone.0089560","article-title":"Activating FLT3 mutants show distinct gain-of-function phenotypes in\u00a0vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia","volume":"9","author":"Janke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2019.09.602_bib20","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2015-12-688705","article-title":"Comprehensive mutational profiling of core binding factor acute myeloid leukemia","volume":"127","author":"Duployez","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2019.09.602_bib22","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4065\/80.11.1517","article-title":"Adult acute lymphoblastic leukemia","volume":"80","author":"Jabbour","year":"2005","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.clml.2019.09.602_bib23","first-page":"23","article-title":"Topics in pediatric leukemia\u2013acute lymphoblastic leukemia","volume":"7","author":"Esparza","year":"2005","journal-title":"MedGenMed"},{"key":"10.1016\/j.clml.2019.09.602_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12032-013-0462-6","article-title":"FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL)","volume":"30","author":"Kabir","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.clml.2019.09.602_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1054\/bjoc.2000.1504","volume":"83","author":"Donadieu","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clml.2019.09.602_bib26","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993","volume":"106","author":"Rowe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib27","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib28","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study","volume":"111","author":"Pullarkat","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib29","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib30","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood-2002-01-0195","article-title":"Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse","volume":"100","author":"Shih","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib31","first-page":"190","article-title":"FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group","volume":"111","author":"Abu-Duhier","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.09.602_bib32","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V100.1.59","article-title":"Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease","volume":"100","author":"Schnittger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib34","first-page":"19","article-title":"Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia","volume":"88","author":"Moreno","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2019.09.602_bib35","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2007-05-091215","article-title":"Prognostic relevance of FLT3-TKD mutations in AML: the combination matters\u2014an analysis of 3082 patients","volume":"111","author":"Bacher","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib36","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2006-04-015826","article-title":"FLT3\u00a0tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia","volume":"110","author":"Mead","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/eji.200839213","article-title":"FLT3 ligand\u2013receptor interaction is important for maintenance of early thymic progenitor numbers in steady-state thymopoiesis","volume":"40","author":"Kenins","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.clml.2019.09.602_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni1216","article-title":"Notch signaling controls the generation and differentiation of early T lineage progenitors","volume":"6","author":"Sambandam","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clml.2019.09.602_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature06839","article-title":"Adult T-cell progenitors retain myeloid potential","volume":"452","author":"Wada","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.clml.2019.09.602_bib40","first-page":"238","article-title":"Human FLT3\/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells","volume":"10","author":"Rosnet","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.09.602_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-3083.2000.00746.x","article-title":"CD135 (Flk2\/FLT3) expression by human thymocytes delineates a possible role of FLT3-ligand in T-cell precursor proliferation and differentiation","volume":"52","author":"Bertho","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clml.2019.09.602_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V83.2.415.415","article-title":"Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood","volume":"83","author":"Dworzak","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.602_bib43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.leu.2403303","article-title":"CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease","volume":"18","author":"Dworzak","year":"2004","journal-title":"Leukemia"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019319895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019319895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:33:58Z","timestamp":1761870838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265019319895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2152265019319895"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.09.602","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.09.602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}